Digital activity tracking to understand metastatic breast cancer care
Official title: Digital Physical Activity in Individuals Living with Metastatic Cancer
Funded at Sloan-Kettering Inst Can Research · NIH-11430629 · Data updated 2026-11-12
A smartphone-based activity tracking study will help people with metastatic cancer better understand how daily movement relates to health and treatment outcomes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 14, 2026 |
| Project end | August 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $751,614 |
| NIH project number | 1R01CA315819-01 |
| Project ID | NIH-11430629 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with metastatic breast cancer who can use a smartphone and are willing to participate in long-term monitoring.
✕Less likely to help
Patients who cannot use smartphones or prefer not to track activity may not benefit.
What this research studies
This project uses smartphone data and other digital health tools to measure physical activity in people living with metastatic cancer. It follows a group of participants over time to see how activity levels relate to treatment responses and overall health. Results could reveal practical ways to monitor wellbeing and guide care decisions through everyday technology. The team combines experts in oncology, digital health, and biostatistics to analyze activity patterns and health outcomes.
Why it matters
Potential benefit: If successful, patients could have a more objective, easy-to-use way to monitor their health and guide treatment decisions through their phone.
How similar studies have gone: Previous studies show activity data can reflect health status, but data in metastatic cancer are limited and this study aims to expand understanding.
Where this research is happening
-
Sloan-Kettering Inst Can Research
New York, United States Active
Researchers
- Principal investigator: Scott, Jessica — Sloan-Kettering Inst Can Research
- Study coordinator: Scott, Jessica
Related research
Other NIH-funded projects on the same topics.
-
Whole-Body Redox Maps to Guide Prostate Cancer Therapy
A new research project will map redox states across the body to understand how prostate cancer and its spread respond to therapy.
-
Measuring how cancer patients and doctors talk to each other to improve treatment outcomes
This project uses machine learning to study how patient-provider conversations affect cancer patients’ use of oral therapies and their health results.
-
Symptoms and quality of life during immunotherapy for metastatic cancer
The team will track symptoms and day-to-day quality of life in people with metastatic cancer who are receiving immune checkpoint inhibitor treatments.
-
A New Treatment for Metastatic Cancer
This project is exploring a brand-new treatment designed to specifically target and remove metastatic cancer cells in people with advanced cancer.
-
How cancer cells release proteins that help tumors spread
This project is learning how tumor cells send out certain proteins that help cancer move to other parts of the body, with the goal of helping people with metastatic cancer.
-
Making palliative care work better for people with metastatic cancer
This project aims to find what helps specialist palliative care give better support and quality of life for people with metastatic cancer.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.